By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Allon Therapeutics, Inc. 

506–1168 Hamilton Street

Vancouver  British Columbia  V6B 2S2  Canada
Phone: 604-736-0634 Fax: 604-736-1616



Company News
Allon Therapeutics, Inc. Receives Court Approval for Proposal and Reorganization 7/11/2013 9:33:03 AM
Allon Therapeutics, Inc. Provides Update to Its Proposal and Reorganization 6/7/2013 11:51:42 AM
Allon Therapeutics, Inc. Filing for Bankruptcy 5/30/2013 10:35:39 AM
Allon Therapeutics, Inc. Announces PSP Clinical Trial Results 12/19/2012 8:39:45 AM
Allon Therapeutics, Inc. Release: the United States, New Zealand & Mexico Issue Patent for New Allon Platform 12/5/2012 9:29:23 AM
Allon Therapeutics, Inc. Selected as Top 10 Partnering Prospect by CNS Experts 11/29/2012 10:02:47 AM
Allon Therapeutics, Inc. Files Preliminary Shelf Prospectus 11/26/2012 10:43:42 AM
Patient Treatment Completed in Pivotal Trial Evaluating Allon Therapeutics, Inc.'s Davunetide 11/13/2012 11:19:27 AM
Allon Therapeutics, Inc. Releases Q3 Operating Results and Provides Corporate Update 11/6/2012 10:17:15 AM
Allon Therapeutics, Inc.'s CEO Presenting at 2012 Biotechnology Industry Organization (BIO) Investor Forum and Updating Guidance 10/11/2012 11:46:04 AM